Turinabol 10 - Pharmacom Labs

Turinabol, or chlorodehydromethyltestosterone, was first described in 1962 and developed by Jenapharm in East Germany. Released as Oral Turinabol, it was designed as a mild, non-estrogenic anabolic for clinical use in men, women, and children. Though effective in preserving muscle and bone mass, it gained notoriety in the 1990s after revelations of its use in the GDR's state-sponsored doping program. Discontinued in 1994 after German reunification, it survives today via underground production.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Turinabol 10 by Pharmacom Labs, consult with your doctor or healthcare professional.